The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine

被引:24
|
作者
Lewis, Deyana D. [1 ]
Cropp, Cheryl D. [2 ]
机构
[1] NHGRI, Computat & Stat Genom Branch, Baltimore, MD 21224 USA
[2] Samford Univ, Dept Pharmaceut Social & Adm Sci, McWhorter Sch Pharm, Birmingham, AL 35229 USA
基金
美国国家卫生研究院;
关键词
prostate cancer; genetics; health disparity; African ancestry; clinical trials; GENOME-WIDE ASSOCIATION; ANDROGEN RECEPTOR GENE; BRCA2 MUTATION CARRIERS; CAG REPEAT LENGTH; 8Q24 RISK ALLELES; AMERICAN MEN; SOCIOECONOMIC-STATUS; CYP17; GENE; SUSCEPTIBILITY LOCUS; CLINICAL-TRIALS;
D O I
10.3390/genes11121471
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Prostate cancer disproportionately affects men of African ancestry at nearly twice the rate of men of European ancestry despite the advancement of treatment strategies and prevention. In this review, we discuss the underlying causes of these disparities including genetics, environmental/behavioral, and social determinants of health while highlighting the implications and challenges that contribute to the stark underrepresentation of men of African ancestry in clinical trials and genetic research studies. Reducing prostate cancer disparities through the development of personalized medicine approaches based on genetics will require a holistic understanding of the complex interplay of non-genetic factors that disproportionately exacerbate the observed disparity between men of African and European ancestries.
引用
收藏
页码:1 / 28
页数:28
相关论文
共 50 条
  • [21] Breast cancer in the era of precision medicine
    Sarhangi, Negar
    Hajjari, Shahrzad
    Heydari, Seyede Fatemeh
    Ganjizadeh, Maryam
    Rouhollah, Fatemeh
    Hasanzad, Mandana
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (10) : 10023 - 10037
  • [22] Lung Cancer in the Era of Precision Medicine
    Politi, Katerina
    Herbst, Roy S.
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2213 - 2220
  • [23] Breast cancer in the era of precision medicine
    Negar Sarhangi
    Shahrzad Hajjari
    Seyede Fatemeh Heydari
    Maryam Ganjizadeh
    Fatemeh Rouhollah
    Mandana Hasanzad
    Molecular Biology Reports, 2022, 49 : 10023 - 10037
  • [24] Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine
    Dulaney, Caleb R.
    Osula, Daniel O.
    Yang, Eddy S.
    Rais-Bahrami, Soroush
    PROSTATE CANCER, 2016, 2016
  • [25] Molecular Characterization of Prostate Cancers in the Precision Medicine Era
    Giunta, Emilio Francesco
    Annaratone, Laura
    Bollito, Enrico
    Porpiglia, Francesco
    Cereda, Matteo
    Banna, Giuseppe Luigi
    Mosca, Alessandra
    Marchio, Caterina
    Rescigno, Pasquale
    CANCERS, 2021, 13 (19)
  • [26] Personalising Prostate Radiotherapy in the Era of Precision Medicine: A Review
    Spence, Winter
    JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2018, 49 (04) : 376 - 382
  • [27] Maximizing the benefits of precision medicine for cancer disparities
    Gehlert, Sarah J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03)
  • [28] Lung Cancer Disparities in the Era of Personalized Medicine
    Lathan, Christopher S.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (02) : 5 - 8
  • [29] Prioritizing precision medicine for prostate cancer
    Attard, G.
    Beltran, H.
    ANNALS OF ONCOLOGY, 2015, 26 (06) : 1041 - 1042
  • [30] Precision medicine in pharmacotherapy for prostate cancer
    Shiota, Masaki
    CANCER SCIENCE, 2023, 114 : 1539 - 1539